MIRANDA BECKLER: Open Payments
NPI 1235605296 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 18 payments from 9 companies in 2025. Trend: 2023 $838 · 2024 $954 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $91 |
| Phathom Pharmaceuticals, Inc. | 3 | $69 |
| Novo Nordisk Inc | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: VOQUEZNA, AREXVY, Rybelsus, FARXIGA, REXULTI, GVOKE HYPOPEN, TRELEGY ELLIPTA, Veozah.
Industry payments across TN — which companies pay providers there.
